Ameritas Investment Company’s Ionis Pharmaceuticals IONS Stock Holding History

Ameritas Investment Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-54	Closed	-$2.43K	–	1370
2021 Q1	$2.43K	Buy	+54	New	+$3.01K	﹤0.01%	1874
2020 Q2	–	Sell	-223	Closed	-$11K	–	944
2020 Q1	$11K	Buy	+223	New	+$12.4K	﹤0.01%	1168
2019 Q4	–	Sell	-262	Closed	-$16K	–	1158
2019 Q3	$16K	Buy	+262	New	+$17.1K	﹤0.01%	994

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Ameritas Investment Company's IONS Position: Q2 2021 in Review

Ameritas Investment Company sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 54 shares — an estimated $2.43K sold.

Ameritas Investment Company first reported a position in IONS in Q3 2019 and held it in 3 quarters. The position peaked at $16K in Q3 2019. 338 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Ameritas Investment Company reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 54 Ionis Pharmaceuticals shares in Q2 2021, an estimated $2.43K.
Ameritas Investment Company first reported a position in Ionis Pharmaceuticals in Q3 2019 and held it in 3 quarters.
Ameritas Investment Company's Ionis Pharmaceuticals position peaked at $16K in Q3 2019.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.